MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2019 International Congress

    Certification of cause of death in patients with Parkinson’s Disease (PD)

    M. Khwaja, A. Chatterjee (Reading, United Kingdom)

    Objective: To evaluate the accuracy of death certification in patients with PD. Background: The National Statistics Office guidance (1) suggests that doctors completing Medical Certificate…
  • 2019 International Congress

    Population Exposure-Response Models of Apomorphine Sublingual Film in Healthy Subjects and Patients With Parkinson’s Disease and “OFF” Episodes

    F. Agbo, Y. Chiu, S. Chapel, G. Galluppi, D. Blum, B. Navia (Fort Lee, NJ, USA)

    Objective: Exposure-response models were developed to characterize the relationship between apomorphine exposure and (1) efficacy using Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease…
  • 2019 International Congress

    A genome wide pleiotropic approach to identify the genetic architecture of multiple system atrophy and its interaction with Parkinson’s disease

    A. Ashokkumar Sreelatha, A. Shadrin, C. Blauwendraat, O. Frei, T. Gasser, G. Wenning, A. Singleton, H. Houlden, S. Scholz, O. Andreassen, M. Sharma (Tübingen, Germany)

    Objective: The aim of this study is to provide new insights into the genetic architecture of multiple system atrophy (MSA) and investigate shared molecular genetic…
  • 2019 International Congress

    Abnormal Intracortical Facilitation in patients of Parkinson’s disease with REM Sleep Behavior Disorder

    A. Bhattacharya, N. Kamble, R. Yadav, PK Pal

    Objective: To evaluate the motor cortical excitability changes in PD patients with and without RBD. Background: There has been an increase in the understanding of…
  • 2019 International Congress

    Identifying Incident Cases of Neurodegenerative Parkinsonism in a Large Observational At-Risk Cohort: the PPMI study

    L. Chahine, K. Kieburtz, M. Brumm, C. Caspell-Garcia, C. Coffey, A. Siderowf, D. Weintraub, C. Tanner, T. Foroud, D. Galasko, B. Mollenhauer, T. Simuni, K. Marek (Pittsburgh, PA, USA)

    Objective: To examine the potential of a data-driven approach to identify incident cases of neurodegenerative parkinsonian disorders (PD) in a large observational cohort of individuals…
  • 2019 International Congress

    Characteristics of African American Parkinson’s Disease patients seen in a Large Clinic Practice

    M. Dean, M. Patel, K. Barnes, D. Standaert (Birmingham, AL, USA)

    Objective: To describe and compare characteristics of African American (AA) and White Parkinson’s Disease (PD) patients seen in a large clinic practice at the University…
  • 2019 International Congress

    Cognition and Gait in Parkinson’s Disease

    A. Fatima (Lahore, Pakistan)

    Objective: Evaluating DT situations in Parkinson Disease is helpful since cognitive functions and motor control—both often impaired in PD—are examined at the same time. However,…
  • 2019 International Congress

    Neuropathy in patients treated with LCIG in the Czech and the Slovak Republic

    P. Havránková, J. Klempíř, J. Roth, E. Růžička, M. Baláž, M. Bareš, I. Rektorová, M. Kaiserová, P. Kaňovský, M. Minár, K. Gmitterová, P. Valkovič, M. škorvánek, V. Haň, L. Skička, J. Necpál, M. Grófik, E. Kurča, R. Jech (Praha, Czech Republic)

    Objective: To identify occurrence, severity and clinical factors associated with neuropathy in patients with Parkinson's disease (PD) treated with LCIG (levodopa – carbidopa intestinal gel)…
  • 2019 International Congress

    Association between transfer activities and health-related quality of life in patients with Parkinson’s disease

    AC. Kalkan, T. Kahraman, BO. Ugut, B. Donmez Colakoglu, A. Genc (Izmir, Turkey)

    Objective: To investigate the association between health-related quality of life (HRQoL) and transfer activities in patients with Parkinson's disease (PD). Background: Bradykinesia, rigidity, tremor and…
  • 2019 International Congress

    Motor Response Inhibition – A potential tool to determine optimum STN-DBS setting

    H. Kumar, A. Roy, S. Choudhury, P. Basu, M. Baker, S. Baker (Kolkata, India)

    Objective: To explore the possibility of using an automated bed side test of motor response inhibition - Stop Signal Reaction Time (SSRT) while optimizing DBS…
  • « Previous Page
  • 1
  • …
  • 113
  • 114
  • 115
  • 116
  • 117
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • #24752 (not found)
    • Effect of Aspartame on Parkinson’s Disease Progression and Severity
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley